EU RNA Vaccine Advancements

2 items

Sat, Apr 18, 2026

EMA Recommends First RNA Veterinary Vaccine

Rights & Society European Medicines Agency

EU recommends first RNA-based vaccine for animals, advancing veterinary medicine.

Tue, Apr 21, 2026

EMA recommends first RNA veterinary vaccine authorisation

Rights & Society European Medicines Agency (EMA)

New RNA vaccine tech for cats approved, setting precedent for animal health in Europe.

Back to digest

Content sourced exclusively from official EU institutions including the European Commission, Parliament, Council, ECB, ESMA, EBA, and other EU agencies. Summaries may contain inaccuracies or omissions. For informational purposes only, not legal, financial, or political advice. Always refer to original sources. Operated by euroneo UG (haftungsbeschränkt) i.G., Germany.

EU Glossary Sources Attention Report Imprint Terms Privacy Telegram

Settings

Sources

Filter

Categories

euroneo

Every day, the EU publishes hundreds of documents. Regulations, consultations, guidelines, spread across dozens of institutions. Most of it goes unread. That's not a tech problem. It's an attention problem.

We read the originals

Not the Reuters summary. The actual Commission press release at 7am. The Council conclusions nobody tweets about. The ESMA consultation buried on page three of their website.

Just the facts

What happened and why it matters. You form your own opinion.

You can't google what you don't know exists

That's the real problem with "just ask an AI." It only finds what you think to search for. Last month the EBA quietly updated its guidelines on interest rate risk. Nobody asked about it. We caught it.

For people who care

Policy, finance, law, or just curious. Free. No account needed.

Imprint Terms Privacy Telegram

euroneo+

The free daily EU digest, 45+ official sources, delivered to your inbox every morning.

I am interested in more daily articles I would prefer more frequent intraday updates

By subscribing you agree to receive our daily email digest. Your email address is used exclusively for sending the digest and is not shared with third parties. You can unsubscribe at any time via the link in every email. Privacy Policy.